Recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms NCT04541082 Conditions Anaplastic Astrocytoma, Anaplastic Meningioma, Anaplastic Oligodendroglioma, +41 more Locations National Institutes of Health — Bethesda, Maryland, United States View Trial Details
Recruiting Predictive Factors for Survival in Aggressive Meningiomas NCT05793034 Conditions Anaplastic Meningioma, Central Nervous System Neoplasms, Meningeal Neoplasms, +9 more Locations Fondazione Policlinico Universitario A. Gemelli IRCCS — Rome, Italy View Trial Details
Completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors NCT03434262 Conditions Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Ganglioglioma, +92 more Locations St. Jude Children's Research Hospital — Memphis, Tennessee, United States View Trial Details
Completed Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 NCT01082926 Conditions Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Meningioma, +33 more Locations City of Hope — Duarte, California, United States View Trial Details
